Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 39

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
 31, 2025 and 2024, depreciation and amortization expense was $3.0 million and $0.8 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and selling, general and administrative ("SG&A") expense. 

24

Table of ContentsINSPIRE MEDICAL SYSTEMS, INC. NOTES TO CONDENSED FINANCIAL STATEMENTS (Unaudited) (Table amounts in thousands, except share and per share amounts)

For the three-month periods ended March 31, 2025 and 2024, stock-based compensation expense was $31.1 million and $26.3 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and SG&A expense. Revenue by geographic region is as follows: Three Months EndedMarch 31,20252024United States$193,606 $155,771 All other countries7,711 8,239 Total revenue$201,317 $164,010 Long-lived tangible assets by geographic location were as follows:March 31, 2025December 31, 2024United States$76,288 $71,008 All other countries887 917 Total long-lived tangible assets$77,175 $71,925 

9. Income (Loss) Per Share

Basic net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. For the periods presented with a net loss, diluted net loss per share is the same as basic net loss per share as all of the following potentially dilutive shares were antidilutive in those periods.The components of net income (loss) per share are as follows:Three Months EndedMarch 31,20252024Numerator:Net income (loss)$2,992 $(10,005)Denominator:Weighted average number of common shares outstanding - basic29,702,358 29,615,166 Dilutive effect of stock options441,165 — Dilutive effect of restricted stock units157,476 — Dilutive effect of shares issuable under the ESPP